SciVision Biotech Inc. (TPE:1786)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
109.00
-0.50 (-0.46%)
Oct 9, 2025, 1:30 PM CST
-0.46%
Market Cap7.87B
Revenue (ttm)891.22M
Net Income (ttm)163.57M
Shares Out72.19M
EPS (ttm)2.21
PE Ratio49.42
Forward PEn/a
Dividend3.25 (2.98%)
Ex-Dividend DateApr 25, 2025
Volume799,654
Average Volume1,074,071
Open109.00
Previous Close109.50
Day's Range107.50 - 110.00
52-Week Range83.50 - 129.50
Beta0.43
RSI76.43
Earnings DateNov 6, 2025

About SciVision Biotech

SciVision Biotech Inc. manufactures and sells hyaluronic acid medical products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in the wholesale of medical equipment; and provides management consulting services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2024, SciVision Biotech's revenue was 883.31 million, an increase of 23.89% compared to the previous year's 712.99 million. Earnings were 242.25 million, an increase of 36.17%.

Financial Statements

News

There is no news available yet.